HK Stock MarketDetailed Quotes

01177 SINO BIOPHARM

Watchlist
  • 3.220
  • +0.110+3.54%
Market Closed Sep 13 16:08 CST
60.51BMarket Cap13.47P/E (TTM)

SINO BIOPHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SINO BIOPHARM H1 FY2024 Earnings Date

Currency：CNYAug 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
15.87B
--
+3.91%
EPS
--
3.28
--
+141.74%
Analyst Rating
Strong Buy

Sep 13, 2024

SINO BIOPHARM Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 31, 20222021/Q46.254B / 6.192B--
--2021/Q36.254B / 6.448B--
Aug 31, 20212021/Q27.111B / 7.370B--
May 24, 20212021/Q17.243B / 6.399B--
Mar 23, 20212020/Q45.521B / 6.237B--
DatePeriodRevenue/EstimateEarnings Call
Mar 31, 20222021/Q46.254B / 6.192B--
--2021/Q36.254B / 6.448B--
Aug 31, 20212021/Q27.111B / 7.370B--
May 24, 20212021/Q17.243B / 6.399B--
Mar 23, 20212020/Q45.521B / 6.237B--

Unlock Free Earnings Estimates

SINO BIOPHARM Earnings Reports

  • SINO BIOPHARM: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024

    Aug 13 04:31 ET

  • SINO BIOPHARM: NOTIFICATION OF BOARD MEETING

    Jul 31 04:36 ET

  • SINO BIOPHARM: 2023 ANNUAL REPORT

    Apr 29 04:42 ET

  • SINO BIOPHARM: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023

    Mar 28 04:31 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 13, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    % Chg

    No Data